The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors
Condition: Gastroesophageal Junction (GEJ) Adenocarcinoma Intervention: Drug: Q-1802 Injection,Oxaliplatin Injection,Capecitabine Sponsor: QureBio Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials